Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women.
作者： Jamie D. Croxtall , Kate McKeage
DOI: 10.2165/11204810-000000000-00000
关键词:
摘要: … extent with the fulvestrant 500 mg regimen than with fulvestrant 250 mg monthly (78.8% vs 47.3%; p<0.0001).[25] The mechanism of the antiproliferative action of fulvestrant in breast …
springer.com
sci-hub.se 参考文章(71)
Antonio C. Wolff, Michaela J. Higgins, Therapeutic options in the management of metastatic breast cancer. Oncology. ,vol. 22, pp. 614- 623 ,(2008)
Christa K Baumann, Monica Castiglione-Gertsch, Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer. Drugs. ,vol. 67, pp. 2335- 2353 ,(2007) , 10.2165/00003495-200767160-00004
Lesley J Scott, Susan J Keam, Letrozole : in postmenopausal hormone-responsive early-stage breast cancer. Drugs. ,vol. 66, pp. 353- 362 ,(2006) , 10.2165/00003495-200666030-00010
Lynda R Wiseman, Lesley J Scott, Management of Hormone-Responsive Postmenopausal Breast Cancer Disease Management & Health Outcomes. ,vol. 13, pp. 337- 354 ,(2005) , 10.2165/00115677-200513050-00006
Anthony Howell, John Pippen, Richard M. Elledge, Louis Mauriac, Ignace Vergote, Stephen E. Jones, Steven E. Come, C. Kent Osborne, John F.R. Robertson, Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma Cancer. ,vol. 104, pp. 236- 239 ,(2005) , 10.1002/CNCR.21163
Anne E. Lykkesfeldt, Per Briand, Mogens W. Madsen, Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Cancer Research. ,vol. 54, pp. 1587- 1595 ,(1994)
Alan E. Wakeling, Michael Dukes, Jean Bowler, A potent specific pure antiestrogen with clinical potential. Cancer Research. ,vol. 51, pp. 3867- 3873 ,(1991)
Roger W. Blamey, Mitchell Dowsett, Michael Baum, Nigel J. Bundred, Alan E. Wakeling, Christobel Saunders, Anthony Howell, Robert I. Nicholson, Elizabeth Anderson, John F. Robertson, Robert E. Mansel, Frances Sutcliffe, David J. DeFriend, Peter Walton, Investigation of a New Pure Antiestrogen (ICI 182780) in Women with Primary Breast Cancer Cancer Research. ,vol. 54, pp. 408- 414 ,(1994)
Ruth C Travis, Timothy J Key, Oestrogen exposure and breast cancer risk Breast Cancer Research. ,vol. 5, pp. 239- 247 ,(2003) , 10.1186/BCR628